Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
184
3.830
Why?
Proteins
17
2010
347
2.300
Why?
Neovascularization, Pathologic
17
2022
158
2.280
Why?
Calixarenes
7
2017
9
1.840
Why?
Melanoma, Experimental
6
2021
34
1.750
Why?
Galectin 1
8
2024
20
1.710
Why?
Antineoplastic Agents
14
2024
1214
1.480
Why?
Peptides
20
2017
234
1.280
Why?
Mice
47
2024
5877
1.210
Why?
Neoplasms
14
2024
1288
1.150
Why?
Animals
53
2024
13332
1.000
Why?
Endothelial Cells
10
2022
281
0.980
Why?
Lung Neoplasms
5
2024
624
0.970
Why?
Gold
7
2023
84
0.850
Why?
Ovarian Neoplasms
8
2008
458
0.830
Why?
Oxygen
6
2020
333
0.800
Why?
Cell Line, Tumor
18
2024
1418
0.760
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
166
0.730
Why?
Carcinoma, Squamous Cell
4
2019
330
0.710
Why?
Proto-Oncogene Proteins c-met
1
2021
19
0.690
Why?
Peptide Fragments
5
2013
207
0.680
Why?
Mammary Neoplasms, Experimental
6
2015
122
0.670
Why?
Radiation-Sensitizing Agents
4
2023
50
0.670
Why?
Head and Neck Neoplasms
3
2019
285
0.650
Why?
Carcinoma, Lewis Lung
1
2019
10
0.630
Why?
Molecular Targeted Therapy
2
2018
132
0.610
Why?
Preservation, Biological
1
2018
9
0.600
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
78
0.600
Why?
Protein Kinase Inhibitors
1
2021
225
0.600
Why?
Radiation Tolerance
5
2020
78
0.590
Why?
CD8-Positive T-Lymphocytes
1
2019
128
0.590
Why?
Anti-Bacterial Agents
4
2019
796
0.580
Why?
Galectins
1
2018
7
0.570
Why?
Metal Nanoparticles
4
2023
66
0.540
Why?
Hyperthermia, Induced
3
2019
114
0.530
Why?
Bacteria
1
2018
220
0.520
Why?
Mice, Nude
12
2019
231
0.520
Why?
Radiotherapy
5
2021
128
0.510
Why?
Xenograft Model Antitumor Assays
11
2020
216
0.490
Why?
Pseudomonas aeruginosa
2
2013
76
0.450
Why?
Combined Modality Therapy
11
2020
634
0.410
Why?
Benzofurans
2
2012
18
0.400
Why?
Cytotoxins
1
2013
15
0.400
Why?
Cell Proliferation
10
2024
1017
0.390
Why?
Drug Design
4
2014
121
0.390
Why?
Oxidation-Reduction
3
2024
326
0.390
Why?
Pseudomonas Infections
1
2013
54
0.390
Why?
Humans
44
2024
52114
0.380
Why?
Endothelium, Vascular
8
2010
257
0.380
Why?
Carbohydrate Metabolism
1
2012
25
0.380
Why?
Nanostructures
3
2023
41
0.370
Why?
Neoplasms, Experimental
4
2020
112
0.370
Why?
Benzeneacetamides
2
2024
12
0.370
Why?
Glutaminase
2
2024
18
0.370
Why?
Bacteremia
1
2013
89
0.370
Why?
Sesquiterpenes
3
2010
92
0.350
Why?
Angiostatic Proteins
1
2011
1
0.350
Why?
Immunity, Cellular
1
2011
62
0.340
Why?
Cell Survival
8
2024
596
0.330
Why?
Molecular Mimicry
2
2007
35
0.330
Why?
Dendritic Cells
3
2021
133
0.330
Why?
Endothelium
4
2022
38
0.320
Why?
Carboplatin
3
2024
56
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1020
0.310
Why?
Tumor Necrosis Factor-alpha
4
2019
392
0.310
Why?
Immunotherapy, Adoptive
1
2011
155
0.300
Why?
Cells, Cultured
8
2013
1568
0.300
Why?
Apoptosis
7
2024
1117
0.300
Why?
Vascular Endothelial Growth Factor A
7
2022
187
0.300
Why?
Intercellular Adhesion Molecule-1
5
2022
59
0.290
Why?
T-Lymphocytes
1
2011
316
0.290
Why?
Structure-Activity Relationship
6
2012
404
0.290
Why?
Polyethylene Glycols
3
2021
91
0.290
Why?
Mice, Inbred C57BL
8
2021
1872
0.290
Why?
Phototherapy
2
2019
26
0.280
Why?
Amino Acid Sequence
5
2012
566
0.280
Why?
Tumor Cells, Cultured
6
2019
445
0.280
Why?
Female
24
2020
28055
0.270
Why?
Drug Resistance, Neoplasm
2
2024
324
0.260
Why?
Magnetic Resonance Spectroscopy
5
2012
252
0.250
Why?
Antibodies, Monoclonal
2
2007
475
0.250
Why?
Blood Vessels
4
2015
72
0.250
Why?
Disease Models, Animal
7
2020
1467
0.240
Why?
Molecular Sequence Data
5
2012
766
0.240
Why?
Nanoparticles
2
2017
127
0.230
Why?
Cell Division
7
2010
288
0.220
Why?
Bystander Effect
1
2024
24
0.220
Why?
Cysteine
1
2024
50
0.220
Why?
Human Umbilical Vein Endothelial Cells
3
2014
102
0.210
Why?
Buthionine Sulfoximine
1
2024
13
0.210
Why?
Nanotubes
2
2021
17
0.210
Why?
Models, Molecular
4
2024
351
0.210
Why?
Flow Cytometry
2
2017
397
0.200
Why?
Thiadiazoles
2
2024
18
0.200
Why?
Cisplatin
1
2024
284
0.180
Why?
Alanine
3
2012
43
0.180
Why?
Protein Binding
3
2012
665
0.180
Why?
Carcinoma, Renal Cell
1
2022
112
0.180
Why?
Binding Sites
2
2012
375
0.180
Why?
Optical Imaging
2
2020
25
0.180
Why?
Silver
2
2021
46
0.170
Why?
Polyurethanes
1
2021
10
0.170
Why?
Kidney Neoplasms
1
2022
182
0.170
Why?
Radiation
1
2020
14
0.170
Why?
Materials Testing
1
2021
55
0.170
Why?
Forkhead Transcription Factors
1
2021
119
0.170
Why?
Spectrum Analysis
1
2020
51
0.170
Why?
Biocompatible Materials
1
2021
65
0.170
Why?
Mice, Inbred BALB C
5
2020
307
0.160
Why?
CD4-Positive T-Lymphocytes
1
2021
163
0.160
Why?
Mice, Knockout
3
2012
893
0.160
Why?
Neoplasm Transplantation
5
2007
86
0.160
Why?
Disease Progression
3
2019
866
0.160
Why?
Oxygen Consumption
1
2020
200
0.160
Why?
Lactose
2
2024
8
0.150
Why?
Spectrum Analysis, Raman
1
2019
42
0.150
Why?
Immunotherapy
1
2020
240
0.150
Why?
Specimen Handling
1
2018
55
0.150
Why?
Time Factors
6
2017
2970
0.140
Why?
Drug Delivery Systems
2
2019
146
0.140
Why?
Biological Assay
1
2018
46
0.140
Why?
Indazoles
1
2018
47
0.140
Why?
Carbohydrates
1
2018
41
0.140
Why?
Feces
1
2018
155
0.140
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
62
0.140
Why?
Temperature
1
2018
164
0.140
Why?
Cell Hypoxia
4
2015
83
0.140
Why?
Histocompatibility Antigens Class II
1
2017
34
0.130
Why?
Neoplastic Cells, Circulating
1
2017
34
0.130
Why?
Tumor Microenvironment
1
2019
246
0.130
Why?
Male
9
2019
26652
0.130
Why?
Drug Therapy, Combination
1
2018
399
0.130
Why?
Epithelial Cells
1
2018
214
0.130
Why?
Cell Line
4
2017
1018
0.130
Why?
Lipopolysaccharides
2
2008
204
0.120
Why?
Umbilical Veins
4
2010
21
0.120
Why?
Enzyme Inhibitors
1
2018
371
0.120
Why?
Molecular Imaging
1
2015
28
0.120
Why?
Leukocytes
3
2006
59
0.120
Why?
Azides
1
2014
9
0.110
Why?
Tumor Burden
2
2013
133
0.110
Why?
Fluorine Radioisotopes
1
2014
25
0.110
Why?
Cell Transformation, Neoplastic
2
2007
184
0.110
Why?
Immunohistochemistry
5
2020
975
0.110
Why?
Interleukin-2
2
2021
68
0.110
Why?
Drug Synergism
2
2005
148
0.100
Why?
Cell Adhesion
3
2006
163
0.100
Why?
Piperacillin
1
2013
24
0.100
Why?
Peptidomimetics
1
2012
2
0.100
Why?
Penicillanic Acid
1
2013
21
0.100
Why?
Agglutination Tests
1
2012
5
0.100
Why?
Allosteric Regulation
1
2012
16
0.100
Why?
Inflammation Mediators
1
2013
115
0.090
Why?
Cell Cycle
1
2013
237
0.090
Why?
Antimicrobial Cationic Peptides
2
2008
30
0.090
Why?
Neoplastic Stem Cells
1
2012
90
0.090
Why?
Up-Regulation
2
2011
459
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Metformin
1
2012
80
0.090
Why?
Glutamine
2
2024
176
0.080
Why?
Fibroblasts
1
2013
358
0.080
Why?
Adjuvants, Immunologic
1
2011
52
0.080
Why?
Chemotherapy, Adjuvant
1
2011
121
0.080
Why?
Cell Movement
4
2006
273
0.080
Why?
Spiro Compounds
1
2010
8
0.080
Why?
Cytokines
1
2013
621
0.080
Why?
Lignans
1
2008
7
0.070
Why?
Salmonella typhimurium
1
2008
42
0.070
Why?
Klebsiella pneumoniae
1
2008
20
0.070
Why?
Amino Acid Substitution
1
2008
79
0.070
Why?
Furans
1
2008
30
0.070
Why?
Surface Properties
1
2007
62
0.070
Why?
Escherichia coli
1
2008
181
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Endotoxins
1
2006
22
0.070
Why?
Vascular Neoplasms
1
2007
17
0.060
Why?
Concept Formation
1
2006
12
0.060
Why?
Gram-Negative Bacteria
1
2006
34
0.060
Why?
Protein Structure, Secondary
2
2003
71
0.060
Why?
Interleukin-8
1
2006
86
0.060
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Protein Engineering
1
2005
18
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
232
0.060
Why?
Cloning, Molecular
1
2005
180
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
147
0.060
Why?
Angiogenic Proteins
1
2004
5
0.060
Why?
Colonic Neoplasms
1
2006
162
0.060
Why?
Dietary Supplements
1
2008
467
0.060
Why?
Feasibility Studies
1
2006
399
0.060
Why?
Protein Unfolding
1
2024
7
0.060
Why?
Histones
1
2006
316
0.060
Why?
Disulfides
1
2024
17
0.050
Why?
Diphtheria Toxin
1
2004
4
0.050
Why?
Mutagenesis, Site-Directed
1
2024
97
0.050
Why?
Protein Folding
1
2024
60
0.050
Why?
Mammary Neoplasms, Animal
1
2004
33
0.050
Why?
Osmosis
1
2003
4
0.050
Why?
Infusion Pumps
1
2003
12
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1368
0.050
Why?
Circular Dichroism
1
2003
42
0.050
Why?
Plasminogen
1
2003
3
0.050
Why?
Serum Albumin
1
2003
57
0.050
Why?
Extracellular Matrix
1
2003
112
0.050
Why?
Immune Tolerance
1
2022
91
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
853
0.050
Why?
Reactive Oxygen Species
1
2024
421
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
277
0.050
Why?
Immune System
1
2021
42
0.040
Why?
Immunity
1
2021
36
0.040
Why?
Melanoma
1
2004
278
0.040
Why?
Ethers
1
2021
8
0.040
Why?
Regenerative Medicine
1
2021
12
0.040
Why?
Tissue Scaffolds
1
2021
40
0.040
Why?
Angiogenesis Inducing Agents
1
2000
7
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
183
0.040
Why?
Adenocarcinoma
1
2004
401
0.040
Why?
Tissue Engineering
1
2021
74
0.040
Why?
Bone Marrow Cells
1
2021
189
0.040
Why?
Mice, Inbred C3H
2
2012
81
0.040
Why?
Gene Expression Profiling
1
2004
1101
0.040
Why?
Skin Neoplasms
1
2004
499
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
4
0.040
Why?
NAD
1
2018
45
0.040
Why?
Inflammation
1
2022
641
0.040
Why?
Microcirculation
2
2010
63
0.040
Why?
Guidelines as Topic
1
2018
111
0.030
Why?
Microscopy, Fluorescence
1
2018
140
0.030
Why?
Glutathione
1
2019
303
0.030
Why?
Phagocytosis
1
2017
53
0.030
Why?
Glycolysis
1
2017
72
0.030
Why?
Transplantation, Heterologous
2
2008
78
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Nitroimidazoles
1
2015
16
0.030
Why?
Microbubbles
1
2015
26
0.030
Why?
Cell Count
1
2015
143
0.030
Why?
Stromal Cells
1
2015
77
0.030
Why?
Pressure
1
2015
102
0.030
Why?
Down-Regulation
2
2006
343
0.030
Why?
Drug Evaluation, Preclinical
1
2015
141
0.030
Why?
Paclitaxel
2
2006
90
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Radiochemistry
1
2014
2
0.030
Why?
Click Chemistry
1
2014
3
0.030
Why?
Random Allocation
1
2015
289
0.030
Why?
Imaging, Three-Dimensional
1
2015
147
0.030
Why?
Recombinant Proteins
2
2006
492
0.030
Why?
Radiotherapy Dosage
1
2015
253
0.030
Why?
Cell Differentiation
1
2017
670
0.030
Why?
Contrast Media
1
2015
173
0.030
Why?
Molecular Structure
1
2014
315
0.030
Why?
Ultrasonography
1
2015
420
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
335
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.020
Why?
Adenylate Kinase
1
2012
10
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
82
0.020
Why?
Rats
2
2008
3146
0.020
Why?
Radiometry
1
2012
127
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
23
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
113
0.020
Why?
Receptors, Progesterone
1
2008
66
0.020
Why?
Estrogen Receptor beta
1
2008
54
0.020
Why?
Estrogen Receptor alpha
1
2008
85
0.020
Why?
Carcinogens
1
2008
193
0.020
Why?
Cell Growth Processes
1
2007
24
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
4
0.020
Why?
Neutralization Tests
1
2006
26
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
72
0.020
Why?
DNA Modification Methylases
1
2006
28
0.020
Why?
Endotoxemia
1
2006
35
0.020
Why?
Acetylation
1
2006
96
0.020
Why?
Methylation
1
2006
126
0.020
Why?
Vimentin
1
2006
32
0.020
Why?
Chick Embryo
1
2006
79
0.020
Why?
Blood Proteins
1
2006
84
0.020
Why?
Gene Silencing
1
2006
120
0.020
Why?
Nucleic Acid Hybridization
1
2006
54
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Transfection
1
2007
366
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
57
0.020
Why?
Zebrafish
1
2006
60
0.020
Why?
Histone Deacetylases
1
2006
51
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
38
0.020
Why?
Pichia
1
2005
8
0.010
Why?
Gene Transfer Techniques
1
2005
44
0.010
Why?
Cyclophosphamide
1
2006
173
0.010
Why?
Neovascularization, Physiologic
1
2005
87
0.010
Why?
Sequence Homology, Nucleic Acid
1
2004
48
0.010
Why?
Membrane Proteins
1
2006
328
0.010
Why?
Indoles
1
2007
276
0.010
Why?
Treatment Outcome
1
2014
5456
0.010
Why?
Necrosis
1
2004
169
0.010
Why?
Skin
1
2007
418
0.010
Why?
Antibodies
1
2004
148
0.010
Why?
In Situ Nick-End Labeling
1
2003
54
0.010
Why?
Base Sequence
1
2004
627
0.010
Why?
Sequence Homology, Amino Acid
1
2003
136
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
580
0.010
Why?
Epigenesis, Genetic
1
2006
401
0.010
Why?
Mice, Transgenic
1
2004
560
0.010
Why?
RNA, Messenger
1
2004
1135
0.010
Why?
Endothelial Growth Factors
1
2000
11
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
15
0.010
Why?
Fibroblast Growth Factor 2
1
2000
35
0.010
Why?
Lymphokines
1
2000
20
0.010
Why?
Scrotum
1
2000
31
0.010
Why?
Interleukin-1
1
2000
103
0.010
Why?
Models, Biological
1
2002
731
0.010
Why?
Breast Neoplasms
1
2004
1199
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description